Researchers create unique DNA biosensor for early stage
disease detection

8th April 2020by admin0

Disease detection at an early stage is one of the
biggest challenges biochemists and materials scientists are trying
to meet by combining their expertise at Missouri S&T. The
researchers used nanotechnology in biomedical diagnostics—a process
called nanodiagnostics—to create a new, ultrasensitive DNA
biosensor. The new sensor could potentially detect DNA-based
biomarkers for early diagnosis of cancer and genetic disorders, as
well as monitor patient responses to therapies.

Leave a Reply

Your email address will not be published. Required fields are marked *

https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
https://nfusion-tech.com/wp-content/uploads/2019/10/Logo_newfusion-footer.png
Subscribe

If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

    New Fusion

    The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

    Subscribe

    If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!

      New Fusion

      The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.

      Copyright ©2024 New Fusion All Rights Reserved

      Designed by FallingBrick